Contact

Our news

Latest news

May 26, 2026
In the mediaInvestmentNew venturepress release

Amsterdam UMC-backed national INFECT-TT programme launched: ready to invests 7 million in accelerated clinical product development for infectious diseases.

InFECT-TT and Infectious Diseases Innovation Fund (IDIF) launching in May 2026
In May 2026, a new initiative will launch to accelerate product development for infectious diseases: the InFECT TT Programme, together with the associated Infectious Diseases Innovation Fund. This initiative is implemented under the umbrella of InFECT-NL and contributes to the pandemic preparedness of the Netherlands.

 

Read more
Filter News Topics
May 26, 2026
In the mediaInvestmentNew venturepress release

Amsterdam UMC-backed national INFECT-TT programme launched: ready to invests 7 million in accelerated clinical product development for infectious diseases.

Read more
March 23, 2026
In the mediaNew venture

Enabling technology for lightweight structures and materials: the story of Eddytec

Read more
February 23, 2026
InvestmentNew venture

Amplio Pharma B.V. recently completed a second closing within their Seed Investment Round in support of the clinical development of NovoBioJect for the treatment of rheumatoid arthritis

Read more
February 18, 2026
In the media

Amsterdam UMC spin-off RSouth is making a big impact on infant health and ICU admissions in the Netherlands

Read more
December 18, 2025

Collaboration Leads to the Incoporation of Pepper Therapeutics: New Research into the Treatment of Pancreatic Cancer

Read more
October 13, 2025
In the mediaInvestmentNew venture

‘Invest International’ invests in Plantics to accelerate international scale up

Read more
October 7, 2025
In the mediaNew venture

InspectT receives convertible loan from Innovatiefonds Noord-Holland

Read more
September 26, 2025
In the mediaNew venture

AviSia Therapeutics receives convertible loan from Innovatiefonds Noord-Holland

Read more
September 8, 2025
In the mediaNew venture

First babies in the Netherlands protected against RSV by Amsterdam UMC invention

Read more
September 3, 2025
In the mediaNew venture

Amplio Pharma receives EMA approval for Phase 1b trial in patients with rheumatoid arthritis

Read more
Contact